Kangtai Biological: Adsorbed Cell-Free Combination Vaccine for Diphtheria, Tetanus, and Pertussis Obtains Approval for Clinical Trials Notification

Kangtai Biological announced that its wholly-owned subsidiary, Beijing Minhai Biotechnology Co., Ltd., developed an adsorbed-free cell pertussis combined vaccine, and today received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration.